Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer

Current Opinion in Urology

Volumn 17, Issue 1, 2007, Pages 39-47

  Pallwein, Leo ^a   Mitterberger, Michael ^a   Gradl, Johann ^a   Aigner, Friedrich ^a   Horninger, Wolfgang ^a   Strasser, Hannes ^a   Bartsch, Georg ^a   Zur Nedden, Dieter ^a   Frauscher, Ferdinand ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Color power Doppler; Contrast agent; Elastography; Prostate cancer; Ultrasound

Indexed keywords

CANCER GRADING; CANCER STAGING; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ELASTOGRAPHY; GLEASON SCORE; GRAY SCALE ECHOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TUMOR BIOPSY;

HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 33845463772     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328011b85c     Document Type: Review

References (49)

1. American Cancer Society. Cancer facts and figures. 2004, Atlanta: American Cancer Society; 2004.
2. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate 1990; 16:39-48.
3. Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Hum Pathol 1992; 23:211-222.
4. Rifkin MD. Ultrasound of the prostate. 2nd ed. Philadelphia: Lippincott-Raven; 1997.
5. Rifkin MD. Prostate cancer: the diagnostic dilemma and the place of imaging in detection and staging. World J Urol 1998; 16:76-80.
6. Bartsch G, Egender G, Hubscher H, Rohr H. Sonometrics of the prostate. J Urol 1982; 127:1119-1121.
7. Rifkin MD, Alexander AA, Pisarchick J, Matteucci T. Palpable masses in the prostate: superior accuracy of US-guided biopsy compared with accuracy of digitally guided biopsy. Radiology 1991; 179:41-47.
8. Spencer JA, Alexander AA, Gomella L, et al. Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Clin Radiol 1994; 49:711-714.
9. Weaver RP, Noble MJ, Weigel JW. Correlation of ultrasound guided and digitally guided directed transrectal biopsies of palpable prostatic abnormalities. J Urol 1991; 145:516-518.
10. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186:509-513.
11. Kelly IM, Lees WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993; 189:153-156.
12. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 1995; 195:86-90.
13. Littrup PJ, Klein RM, Gross ML, et al. Color Doppler of the prostate: histologic and racial correlations. Radiology 1995; 197:365. [abstract].
14. Ismail M, Petersen RO, Alexander AA, et al. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 1997; 50:906-912.
15. Ismail M, Gomella LG, Alexander AA. Color Doppler sonography of the prostate. Tech Urol 1997; 3:140-146.
16. Alexander AA. To color Doppler image the prostate or not: that is the question. Radiology 1995; 195:11-13.
17. Rifkin MD, Alexander AA, Helinek TG, Merton DA. Color Doppler as an adjunct to prostate ultrasound. Scand J Urol Nephrol Suppl 1991; 137:85-89.
18. Sillman F, Boyce J, Fruchter R. The significance of atypical vessels and neovascularization in cervical neoplasia. Am J Obstet Gynecol 1981; 139:154-159.
19. Srivastava A, Laidler P, Davies RP, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988; 133:419-423.
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
21. Brawer MK, Deering RE, Brown M, et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994; 73:678-687.
22. Fleischer AC, Rodgers WH, Rao BK, et al. Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med 1991; 10:563-568.
23. Cho JY, Kim SH, Lee SE. Diffuse prostatic lesions: role of color and power Doppler ultrasonography. J Ultrasound Med 1998; 17:283-287.
24. Halpern EJ, Sirup SE. Using Gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR 2000; 174:623-627.
25. Louvar E, Littrup PJ, Goldstein A, et al. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83:135-140.
26. Remzi M, Dobrovits M, Reissigl A, et al. Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 2004; 46:451-456.
27. Kedar RP, Cosgrove D, McCready VR, et al. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 1996; 198:679-686.
28. Forsberg F, Merton DA, Liu JB, et al. Clinical applications of ultrasound contrast agents. Ultrasonics 1998; 36:695-701.
29. Forsberg E, Liu JB, Burns PN, et al. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994; 13:357-365.
30. Frauscher E, Helweg G, Gotwald TF, et al. The value of contrast-enhanced color Doppler ultrasonography in the diagnosis of postate cancer. Radiology 1998; 209:417. [abstract].
31. Bree RL, DeDreu SE. Contrast enhanced color Doppler of the prostate as an adjunct to gray-scale identification of cancer prior to biopsy. Radiology 1998; 209:418.
32. Bogers HA, Sedelaar JP, Beerlage HP, et al. Contrast enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54:97-104.
33. Unal D, Sedelaar JP, Aarnink RG, et al. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 2000; 86:58-64.
34. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002; 167:1648-1652.
35. Pelzer A, Bektic J, Berger AP, et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 2005; 173:1926-1929. This is the only paper in the literature about the combined use of contrast-enhanced color Doppler-targeted biopsy (CECD) and systematic transrectal gray scale ultrasound-guided biopsy for the prostate cancer detection in men with prostate specific antigen (PSA) 4-10 ng/ml. The combined use of the two methods allowed for maximal detection of prostate cancer with a detection rate of 37.6% in patients with PSA 4-10 ng/ml.
36. Sedelaar JP, Van Leenders GJ, Hulsbergen-Van De Kaa CA, et al. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 2001; 40:285-293.
37. Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color Doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res 2001; 21:2907-2913.
38. Albrecht T, Hoffmann CW, Schettler S, et al. B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 2000; 216:273-278.
39. Halpern EJ, Verkh L, Forsberg F, et al. Initial experience with contrast-enhanced sonography of the prostate. AIR 2000; 174:1575-1580.
40. Halpern EJ, Rosenberg M, Gomolla LG. Contrast enhanced sonography of the prostate. Radiology 2001; 219:219-225.
41. Halpern EJ, Ramey JR, Strup SE, et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 2005; 104:2373-2383. In this work, contrast-enhanced sonography using IHI was used for prostate biopsy. The study population of 301 men is one of the biggest using intermittent harmonic imaging. This new technique provides a significant improvement in discrimination between benign and malignant biopsy sites.
42. Ophir J, Cespedes I, Ponnekanti H, et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imag 1991; 13:111-134.
43. Klauser A, Kopplestaetter F, Berger AP, et al. Real-time elastography for prostate cancer detection: preliminary experience. Radiology 2003; 229 (Suppl):139. [abstract].
44. Konig K, Scheipers U, Pesavento A, et al. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol 2005; 174:115-117. This is the first paper which validated real-time elastography for prostate cancer detection in 404 men. It could be shown that it is possible to detect prostate cancer with a high degree of sensitivity using real-time elastography in conjunction with conventional diagnostic methods for guided prostate biopsies.
45. Shi WT, Forsberg F, Hall AL, et al. Subharmonic imaging with contrast agents: initial results. Ultrason Imaging 1999; 21:79-94.
46. Forsberg F, Shi WT, Goldberg BB. Subharmonic imaging of contrast agents. Ultrasonic 2000; 38:93-98.
47. Huber S, Delorme S, Knopp MV, et al. Breast tumors: computer-assisted quantitative assessment with color Doppler US. Radiology 1994; 192:797-801.
48. Cosgrove DO, Bamber JC, Davey JB, et al. Color Doppler signals from breast tumors. Work in progress. Radiology 1990; 176:175-180.
49. Huber S, Helbich T, Kettenbach J, et al. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US-early experience. Radiology 1998; 208:485-489.